HomeRoyal Philips

Royal Philips

Philips Enrolls 1st Patient in the WE-TRUST Global Multicenter Stroke Study

The first patient enrolled in global multi-center randomized controlled trial with 564 patients at 15 sites comparing the impact of the Direct to Angio Suite workflow (diagnosis and treatment in the angio suite) to the conventional workflow (diagnosis in the CT or MRI suite followed by treatment in the angio suite) on stroke patient outcomes. WE-TRUST trial to provide most comprehensive assessment to date with the help of an advanced brain scan technology in the angio suite for more effective and efficient stroke patient outcomes.

First Patient Treated with Philips New Real-time 3D Intracardiac Echocardiography Catheter – VeriSight Pro

DA 510k-cleared real-time 3D intracardiac echocardiography (ICE) catheter has the potential to improve the standard of care for structural heart disease and electrophysiology procedures. Reduced need for general anesthesia accelerates workflows, increases efficiency, and broadens treatment options.

DEFINE GPS Global Multicenter Study – First Patient Enrolled: Study to assess Superiority of PCI Procedures Guided by Co-registered iFR and Interventional Angiography

The global, multi-center, prospective, randomized controlled DEFINE GPS study will investigate if guidance by instantaneous wave-free ratio (iFR) measurements co-registered on the angiogram demonstrates superior outcomes and improves the cost-effectiveness of percutaneous coronary intervention (PCI) procedures to open blocked coronary arteries.

Philips and Elekta Deepen Their Existing Partnership

Healthcare leaders partner to streamline the path from cancer diagnosis to survivorship for better outcomes

Philips and Akumin Partner

Partnership leverages Philips’ latest Radiology Operations Command Center to improve the access, quality, and productivity of Akumin’s outpatient imaging center network.

Philips Introduces Integrated Interventional Hemodynamic System with Patient Monitor IntelliVue X3

The integration provides the opportunity for monitoring during image-guided procedures on the Philips Image Guided Therapy System – Azurion, improving workflow with comprehensive patient records that support timely clinical decision-making during interventional cardiology procedures and beyond.

Royal Philips 130 Years of Innovation, Collaboration, and Social Responsibility

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today celebrated 130 years of innovation, collaboration, and social responsibility. During its rich history since being founded on May 15, 1891, in Eindhoven in the...

Philips, American College of Cardiology and MedAxiom Collaborate to Shape the Future of Cardiovascular Care Delivery

The goal of the collaboration is to drive significant performance improvements in integrated cardiovascular care in terms of the patient and care provider experience, clinical outcomes, and productivity.